Wang Y - Search Results

1

Causal pathways for CCR5 genotype and HIV progression.

Taylor JM, Wang Y, Ahdieh L, Chmiel JS, Detels R, Giorgi JV, Kaslow R, Kingsley L, Margolick J. Taylor JM, et al. Among authors: wang y. J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):160-71. doi: 10.1097/00126334-200002010-00008. J Acquir Immune Defic Syndr. 2000. PMID: 10737431

2

Surrogate markers and joint models for longitudinal and survival data.

Taylor JM, Wang Y. Taylor JM, et al. Among authors: wang y. Control Clin Trials. 2002 Dec;23(6):626-34. doi: 10.1016/s0197-2456(02)00234-9. Control Clin Trials. 2002. PMID: 12505241

3

Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.

Nishanian P, Hofmann B, Wang Y, Jackson AL, Detels R, Fahey JL. Nishanian P, et al. Among authors: wang y. AIDS. 1991 Jul;5(7):805-12. doi: 10.1097/00002030-199107000-00003. AIDS. 1991. PMID: 1909873

4

The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.

Bass HZ, Hardy WD, Mitsuyasu RT, Taylor JM, Wang YX, Fischl MA, Spector SA, Richman DD, Fahey JL. Bass HZ, et al. Among authors: wang yx. J Acquir Immune Defic Syndr (1988). 1992;5(3):215-21. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1346807 Clinical Trial.

5

Inference for smooth curves in longitudinal data with application to an AIDS clinical trial.

Wang Y, Taylor JM. Wang Y, et al. Stat Med. 1995 Jun 15;14(11):1205-18. doi: 10.1002/sim.4780141106. Stat Med. 1995. PMID: 7667561 Clinical Trial.

6

Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.

Hofmann B, Wang YX, Cumberland WG, Detels R, Bozorgmehri M, Fahey JL. Hofmann B, et al. Among authors: wang yx. AIDS. 1990 Mar;4(3):207-14. AIDS. 1990. PMID: 1972020

7

Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment.

Bass HZ, Hardy WD, Mitsuyasu RT, Wang YX, Cumberland W, Fahey JL. Bass HZ, et al. Among authors: wang yx. J Acquir Immune Defic Syndr (1988). 1992;5(9):890-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1512689 Clinical Trial.

8

Nanoparticle Adjuvants Incorporating Haptens Drive Potent Immune Tolerance to Accelerate Hair Regrowth.

An N, Yasen G, Li X, Shi X, Wang Y, Liu H. An N, et al. Among authors: wang y. ACS Appl Mater Interfaces. 2025 Jan 17. doi: 10.1021/acsami.4c17068. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39818727

9

Characterizing the Transient Emission of Particles and Gases from a Single Puff of Electronic Cigarette Smoke.

Kapiamba KF, Achterberg S, Lin TC, Whitefield PD, Huang YW, Wang Y. Kapiamba KF, et al. Among authors: wang y. Chem Res Toxicol. 2025 Jan 17. doi: 10.1021/acs.chemrestox.4c00420. Online ahead of print. Chem Res Toxicol. 2025. PMID: 39818726

10

Enhancing Biodegradation of Insoluble High Molecular Weight Polycyclic Aromatic Hydrocarbons in Macroemulsion (ME) Bioreactors with a Liquid-Liquid Interface.

Han K, Li R, Lu Y, Sun X, Cui J, Wang YZ, Wang Y, Lv H, Hu Y, Mi L. Han K, et al. Among authors: wang yz, wang y. ACS Appl Mater Interfaces. 2025 Jan 16. doi: 10.1021/acsami.4c20707. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39818717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,379 results

Search Page

Filters